Related references
Note: Only part of the references are listed.Cellular interactions of platinum drugs
Ezequiel Wexselblatt et al.
INORGANICA CHIMICA ACTA (2012)
Cytotoxicity and DNA interactions of some platinum(II) complexes with substituted benzimidazole ligands
Azime Berna Ozcelik et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2012)
Structure-cytotoxicity relationship for different types of mononuclear platinum(II) complexes with 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine
Iwona Lakomska et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Drug transporters of platinum-based anticancer agents and their clinical significance
Herman Burger et al.
DRUG RESISTANCE UPDATES (2011)
Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials
M. M. Regan et al.
ANNALS OF ONCOLOGY (2010)
Synthesis, characterization, cytotoxicity, and DNA binding of some new platinum(II) and platinum(IV) complexes with benzimidazole ligands
Semra Utku et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2010)
Strategies to Improve the Efficacy of Platinum Compounds
Giacomo Cossa et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting
Katherine S. Lovejoy et al.
DALTON TRANSACTIONS (2009)
Synthesis, Cytotoxicity, and DNA Interactions of New Cisplatin Analogues Containing Substituted Benzimidazole Ligands
Fatma Gumus et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Status of Non-Classical Mononuclear Platinum Anticancer Drug Development
Jinchao Zhang et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Molecular mechanisms of resistance and toxicity associated with platinating agents
Cara A. Rabik et al.
CANCER TREATMENT REVIEWS (2007)
Synthesis, multinuclear magnetic resonance and crystal structures of Pt(II) complexes containing amines and bidentate carboxylate ligands
Fernande D. Rochon et al.
INORGANICA CHIMICA ACTA (2006)
Kinetics of carboplatin-DNA binding in genomic DNA and bladder cancer cells as determined by accelerator mass spectrometry
Sang Soo Hah et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2006)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Synthesis, in vitro cytotoxic and antiviral activity of cis-[Pt(R(-) and S(+)-2-α,-hydroxybenzylbenzimidazole)2Cl2] complexes
M Gökçe et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2005)
Synthesis, characterization and in vitro cytotoxic, mutagenic and antimicrobial activity of platinum(II) complexes with substituted benzimidazole ligands
F Gümüs et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2003)
Synthesis and characterization of Pt(II) complexes with amine and carboxylato ligands.: Crystal structure of (1,1-cyclobutanedicarboxylato)di(ethylamine)platinum(II)•H2O
FD Rochon et al.
INORGANICA CHIMICA ACTA (2000)
Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin
Q He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
